Samsara Bio Capital, LLC Immunocore Holdings PLC Transaction History

Samsara Bio Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $3.73 Million - $5.32 Million	80,963 New	80,963 $4 Million
Q3 2022 Nov 14, 2022	SELL	$37.34 - $57.44 $2.99 Million - $4.6 Million	-80,000 Reduced 49.7%	80,963 $3.8 Million
Q1 2022 May 16, 2022	BUY	$18.94 - $34.29 $1.84 Million - $3.32 Million	96,963 Added 151.5%	160,963 $4.81 Million
Q2 2021 Aug 17, 2021	SELL	$32.22 - $41.5 $515,520 - $664,000	-16,000 Reduced 20.0%	64,000 $2.5 Million
Q1 2021 May 18, 2021	BUY	$36.3 - $56.34 $2.9 Million - $4.51 Million	80,000 New	80,000 $3.41 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.